Largest biotech by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Amgen leads the 21 biotech ranked by revenue, at THB 1.25T, ahead of Gilead Sciences (THB 999.6B) and Biogen (THB 335.8B). Figures as of 18 Nov 2026, 16:06 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 21
- First
- AmgenTHB 1.25T
- Median
- THB 41.3B
- Combined market value
- THB 28.56T
- Countries
- 5
- Not ranked
- 3no revenue on file
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | THB 1.25T | THB 8.22T | THB 15,199.92 | 2.23% down | 34% up | ||
| 2 | Gilead SciencesGILD · Health Care | THB 999.6B | THB 7.11T | THB 5,732.46 | 0.83% down | 33% up | ||
| 3 | BiogenBIIB · Health Care | THB 335.8B | THB 1.26T | THB 8,500.91 | 0.16% down | 49% up | ||
| 4 | argenxARGX · Health Care | THB 140.9B | THB 2.02T | THB 32,191.73 | 0.07% up | 4% up | ||
| 5 | BioNTechBNTX · Health Care | THB 108.1B | THB 709.1B | THB 2,860.29 | 0.72% down | 16% down | ||
| 6 | Neurocrine BiosciencesNBIX · Health Care | THB 97.1B | THB 559.8B | THB 5,530.79 | 1.81% down | 20% up | ||
| 7 | ExelixisEXEL · Health Care | THB 78.8B | THB 571.8B | THB 2,343.23 | 0.76% up | 63% up | ||
| 8 | QiagenQGEN · Health Care | THB 71B | THB 347.7B | THB 1,683.58 | 0.32% down | 12% up | ||
| 9 | ModernaMRNA · Health Care | THB 66B | THB 2.78T | THB 6,860.28 | 2.29% down | 755% up | ||
| 10 | Halozyme TherapeuticsHALO · Health Care | THB 47.4B | THB 377.2B | THB 3,308.43 | 1.54% up | 37% up | ||
| 11 | Bio-TechneTECH · Health Care | THB 41.3B | THB 387.9B | THB 2,469.35 | 0.14% up | 26% up | ||
| 12 | RepligenRGEN · Health Care | THB 25.1B | THB 374.4B | THB 5,856.38 | 6.36% up | 5% up | ||
| 13 | Krystal BiotechKRYS · Health Care | THB 13.2B | THB 311.4B | THB 10,507.36 | 3.67% up | 46% up | ||
| 14 | Twist BioscienceTWST · Health Care | THB 12.8B | THB 268.1B | THB 3,932.43 | 3.42% up | 340% up | ||
| 15 | Adaptive BiotechnologiesADPT · Health Care | THB 9.4B | THB 157B | THB 969.95 | 0.28% up | 88% up | ||
| 16 | ImmunityBioIBRX · Health Care | THB 3.8B | THB 238.9B | THB 224.58 | 5.67% up | 193% up | ||
| 17 | Kymera TherapeuticsKYMR · Health Care | THB 1.3B | THB 349.6B | THB 4,095.05 | 0.74% down | 87% up | ||
| 18 | CG OncologyCGON · Health Care | THB 137.2M | THB 241.5B | THB 2,703.78 | 0.89% up | 85% up | ||
| 19 | CRISPR TherapeuticsCRSP · Health Care | THB 119.2M | THB 136.6B | THB 1,407.90 | 3.29% up | 21% down | ||
| 20 | Revolution MedicinesRVMD · Health Care | THB 0 | THB 1.18T | THB 5,433.70 | 1.62% down | 131% up | ||
| 21 | Scholar Rock HoldingSRRK · Health Care | THB 0 | THB 196.7B | THB 1,612.63 | 5.37% up | 14% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 33.9500 THB). 3 companies have no revenue on file and are not ranked here.
Questions and answers
Which biotech rank first by revenue?
Amgen (THB 1.25T), Gilead Sciences (THB 999.6B) and Biogen (THB 335.8B) are the top three of the 21 biotech ranked by revenue as of 18 Nov 2026, 16:06 UTC.
How many biotech are in this ranking?
21 are ranked by revenue. 3 more have no revenue on file and are left out rather than ranked at zero.
What are these biotech worth together?
The 21 biotech ranked by revenue have a combined market value of THB 28.56T as of 18 Nov 2026, 16:06 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest biotech by revenue”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.